CRL — Charles River Laboratories International Share News
0.000.00%
Last trade - 00:00- $14.62bn
- $17.10bn
- $4.02bn
U.S. RESEARCH ROUNDUP-eBay, Huntsman, Palo Alto
Charles River forecasts upbeat 2026 profit on improved demand for drug development services (updated)
Charles River forecasts upbeat 2026 profit on improved demand for drug development services
Charles River Q4 revenue slightly beats expectations
Brief: Charles River Laboratories Announces Executive Appointments
U.S. RESEARCH ROUNDUP-Alphabet, Micron Technology, Microsoft
U.S. RESEARCH ROUNDUP-Cencora, Kennametal, Regeneron Pharmaceuticals
Charles River to buy Cambodia-based monkey supplier for $510 million
Brief: Charles River Laboratories Provides Business Updates
Brief: Charles River Laboratories Announces Planned Retirement Of James C. Foster
Life sciences and contract research stocks navigate turbulence in 2025
Brief: Charles River Laboratories International Inc - Dsa Net Book-To-Bill Improved Each Month Since Q3 2025 - SEC Filing
U.S. RESEARCH ROUNDUP-Green Brick Partners, Pultegroup, Toll Brothers
Brief: Charles River Laboratories International Inc - SEC Concludes Investigation, No Action Against Charles River Labs - SEC Filing
U.S. RESEARCH ROUNDUP-Doordash, Honeywell, Zscaler
U.S. RESEARCH ROUNDUP-Acadia Pharmaceuticals, Applovin Corp, Centuri Holdings
Charles River plans to sell underperforming assets, ramp up cost cutting (updated)
Charles River raises annual profit forecast on stabilizing biotech demand
Charles River Laboratories Q3 revenue beats estimates